Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatobiliary infections.

D C Rockey1

  • 1Department of Medicine and The Liver Center, Duke University Medical Center, Durham, North Carolina 27710, USA. dcrockey@acpub.duke.edu

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.

Digestive diseases and sciences·2016
Same author

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.

Molecular genetics and metabolism·2013
Same author

Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis.

Alimentary pharmacology & therapeutics·2009
Same author

Heptaobiliary infections.

Current opinion in gastroenterology·2006
Same author

Diagnosis and management of lower gastrointestinal bleeding.

Current opinion in gastroenterology·2006
Same author

Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.

Journal of viral hepatitis·2006

Hepatobiliary infections like liver abscess have seen evolving management strategies. While amebic liver abscess has an excellent prognosis with new diagnostics, pyogenic liver abscess presents greater challenges, shifting from surgery to interventional techniques.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Major hepatobiliary infections include amebic liver abscess, pyogenic liver abscess, and cholangitis.
  • Management of liver abscess has evolved significantly over the past two decades.
  • Cholangitis has seen limited new information published recently.

Purpose of the Study:

  • To review the evolving clinical presentation and management of liver abscess.
  • To highlight recent advancements in the diagnosis and treatment of amebic and pyogenic liver abscess.
  • To compare the prognoses and patient populations associated with amebic versus pyogenic liver abscess.

Main Methods:

  • Literature review focusing on clinical presentation and management of liver abscess.
  • Analysis of recent diagnostic advancements, including serologic tests and molecular techniques for amebic liver abscess.

Related Experiment Videos

  • Examination of treatment trends, contrasting historical surgical approaches with current interventional techniques for pyogenic liver abscess.

    • Main Results:

    • Amebic liver abscess diagnosis is improving with new serologic and molecular methods; prognosis is excellent with proper management.
    • Pyogenic liver abscess is often cryptogenic or linked to underlying conditions and interventions like chemoembolization.
    • Pyogenic liver abscess management has shifted from surgery to interventional techniques, with greater associated morbidity and mortality compared to amebic liver abscess.

    Conclusions:

    • Liver abscess management has markedly changed, with interventional techniques largely replacing surgery for pyogenic forms.
    • While amebic liver abscess has a favorable prognosis, pyogenic liver abscess carries higher risks, particularly in complex cases.
    • Continued advancements in diagnostics and treatment are crucial for improving outcomes in hepatobiliary infections.